newsfilter
← Latest News
PR Newswire·

Immunic, Inc. Announces 1-for-10 Reverse Stock Split

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases (the...